Sildenafil for Microvasculopathy in Chronic TBI — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Sildenafil for Microvasculopathy in Chronic TBI — Stella

Home/Traumatic Brain Injury/

View on ClinicalTrials.gov

Recruiting

Back to Traumatic Brain Injury trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of Pennsylvania, Philadelphia, Pennsylvania

Key details

Phase

Safety & dosing

Sponsor

University of Pennsylvania

Collaborators

Walter Reed National Military Medical Center

Enrollment target

~160 participants

Started

July 2024

Primary completion

December 2027

Age range

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

18 Years – 70 Years

Last updated December 2025